pyridostigmine bromide has been researched along with Congenital Disorders of Glycosylation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domingo Jiménez, R; Ghandour-Fabre, D; Ibáñez-Micó, S; Pérez-Cerdá, C | 1 |
1 other study(ies) available for pyridostigmine bromide and Congenital Disorders of Glycosylation
| Article | Year |
|---|---|
Congenital myasthenia and congenital disorders of glycosylation caused by mutations in the DPAGT1 gene.
Topics: Autism Spectrum Disorder; Child; Cholinesterase Inhibitors; Congenital Disorders of Glycosylation; Humans; Mutation; Myasthenic Syndromes, Congenital; N-Acetylglucosaminyltransferases; Pyridostigmine Bromide | 2019 |